Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

Overview of attention for article published in Journal of Translational Medicine, June 2009

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 Wikipedia article.

Dr. Von Hoff's major interest is in the development of new anticancer agents, both in the clinic and in the laboratory.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.